Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA
Anthony J Mutsaers, Alvin JM Ng, Emma K Baker, Megan R Russell, Alistair M Chalk, Meaghan Wall, Brain JJ Liddicoat, Patricia WM Ho, John L Slavin, Ankita Goradia, T John Martin, Louise E Purton, Ross A Dickins, Carl R Walkley
BONE | ELSEVIER SCIENCE INC | Published : 2013
This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC; to C.W. and C.W./T.J.M.); AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research (C.W.); NHMRC Career Development Award (C.W.); NHMRC Senior Research Fellowship (LP.); Victorian Cancer Agency Early Career Seed Grant (C.W.); Victorian Cancer Agency Clinical Research Fellowship (M.W.); Cancer Therapeutics CRC (CTx) postgraduate scholarship (A.N.); Cure Cancer Australia Fellowship (E.B.); and in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute). C.W. is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation.